1. Home
  2. SUNS vs ANIX Comparison

SUNS vs ANIX Comparison

Compare SUNS & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunrise Realty Trust Inc.

SUNS

Sunrise Realty Trust Inc.

SELL

Current Price

$6.46

Market Cap

108.7M

Sector

Real Estate

ML Signal

SELL

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

SELL

Current Price

$2.78

Market Cap

114.0M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SUNS
ANIX
Founded
2023
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
108.7M
114.0M
IPO Year
2024
2013

Fundamental Metrics

Financial Performance
Metric
SUNS
ANIX
Price
$6.46
$2.78
Analyst Decision
Buy
Strong Buy
Analyst Count
4
4
Target Price
★ $10.50
$9.75
AVG Volume (30 Days)
102.1K
★ 291.2K
Earning Date
11-12-2026
09-09-2026
Dividend Yield
★ 18.90%
N/A
EPS Growth
N/A
★ 12.82
EPS
★ 0.54
N/A
Revenue
★ $21,571,434.00
$210,000.00
Revenue This Year
$89.71
N/A
Revenue Next Year
$11.95
N/A
P/E Ratio
$11.76
★ N/A
Revenue Growth
★ 102.96
N/A
52 Week Low
$5.77
$2.32
52 Week High
$10.45
$5.46

Technical Indicators

Market Signals
Indicator
SUNS
ANIX
Relative Strength Index (RSI) 44.81 44.52
Support Level $5.77 $2.62
Resistance Level $7.90 $3.09
Average True Range (ATR) 0.29 0.15
MACD 0.03 -0.00
Stochastic Oscillator 45.58 31.25

Price Performance

Historical Comparison
SUNS
ANIX

About SUNS Sunrise Realty Trust Inc.

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS, and debt-like preferred equity securities across CRE asset classes and investment mix to include high-quality multi-family, condominiums, retail, office, hospitality, industrial, mixed-use, and specialty-use real estate. The company's portfolio is concentrated in the Southern U.S.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Share on Social Networks: